Table 4.
Types and concentrations of gel-forming agents used in ethosomal gel preparations
Drug/agent | Gel-forming agent
|
Reference(s) | |
---|---|---|---|
Name | Concentration | ||
Amphotericin B | Carbopol 934 | 1% w/w | 100 |
Econazole nitrate | Carbopol 934 | 1% w/w | 40 |
Ketoconazole | Carbopol 934 | 2% w/w | 84 |
Lopinavir | Carbopol 934 | 0.8% w/v | 35 |
Losartan | Carbopol 934 | 0.75% w/v | 96 |
Meloxicam | Carbopol 934 | 1% w/w | 101 |
Testosterone | Carbopol 934 | NM | 102 |
Tretinoin | Carbopol 934 | 1.5% w/w | 78 |
Valsartan | Carbopol 934 | NM | 51 |
5-Fluorouracil | Carbopol 934P | 1.5% w/w | 32 |
Aceclofenac | Carbopol 934P | 0.75% w/v | 15 |
Azelaic acid | Carbopol 934P | 0.75% w/w | 97 |
Methoxsalen | Carbopol 934P | 2% w/w | 103 |
Vinpocetine | Carbopol 934P | 1% w/w | 104 |
Clotrimazole | Carbopol 934LR | 1% w/v | 14 |
Psoralen | Carbopol 934LR | 1% w/v | 92 |
Benzocaine | Carbopol 940 | 0.5% w/w | 66 |
Black-tea extracts | Carbopol 940 | NM | 28 |
Buspirone hydrochloride | Carbopol 940 | 0.7% w/w | 72 |
Capsaicin and capsicum tincture | Carbopol 940 | 1% w/w | 105 |
Ligustrazine phosphate | Carbopol 940 | 1% w/w | 106 |
Repaglinide | Carbopol 940 | 1.5% w/w | 53 |
Valsartan | Carbopol 940 | 1% w/w | 107 |
Erythromycin | Carbopol 974 | 1% w/w | 108 |
Erythromycin | Carbopol 974 | NM | 109 |
Cetirizine | Carbopol 980 NF | 1.25% | 98 |
Griseofulvin | Carbopol 980 NF | 0.5% w/w | 110 |
5-Fluorouracil | Carbopol ultrez | 0.8% w/w | 18 |
Ibuprofen | Carbopol (grade NM) | NM | 111 |
Felodipine | Hydroxypropyl cellulose | 1.5% w/v | 112 |
Fluconazole | Hydroxypropyl methyl cellulose K4M | 2% w/w | 113 |
Mitoxantrone | Hydroxypropyl methylcellulose RG4T | 10% w/v | 114 |
Salbutamol sulfate | Pluronic F127 | 20% w/w | 39 |
Granisetron hydrochloride | Lutrol F127 | 20% w/w | 115 |
Metronidazole | Sodium alginate | 8% w/v | 116 |
Cannabidiol | NM | NM | 117 |
Diclofenac | NM | NM | 8 |
Abbreviation: NM, not mentioned.